FG
GILD icon

Foster Group’s Gilead Sciences GILD Stock Holding History

Foster Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Sell
2,190
-125
-5% -$16.5K 0.01% 256
2026
Q1 		$323K Buy
2,315
+290
+14% +$40.6K 0.01% 204
2025
Q4 		$249K Buy
2,025
+116
+6% +$14.1K 0.01% 243
2025
Q3 		$212K Buy
1,909
+43
+2% +$4.89K 0.01% 252
2025
Q2 		$207K Buy
+1,866
New +$199K 0.01% 248

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Foster Group's GILD Position: Q2 2026 in Review

Foster Group reduced its Gilead Sciences (GILD) stake by 5.4% in Q2 2026, selling an estimated $16.5K and leaving 2,190 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #256.

Foster Group first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $323K in Q1 2026. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Foster Group held 2,190 shares of Gilead Sciences worth $277K as of Q2 2026.
  • Foster Group sold 125 Gilead Sciences shares in Q2 2026, an estimated $16.5K.
  • Gilead Sciences made up 0.01% of Foster Group's portfolio in Q2 2026, its #256 holding.
  • Foster Group first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Foster Group's Gilead Sciences position peaked at $323K in Q1 2026.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Foster Group's 13F filing for Q2 2026, filed 7 Jul 2026.